Bid Price | 180.00p | High Price | 190.00p |
---|
Ask Price | 190.00p | Low Price | 185.50p |
---|
Open Price | 185.00p | Spread | 5.26% |
---|
Prev Close | 185.00p | Volume | 3,244 |
---|
Faron Pharmaceuticals Oy Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Sep 12, 2025 | 185.00 | 190.00 | 185.50 | 185.00 | 3,244 |
Sep 11, 2025 | 187.50 | 190.00 | 180.00 | 185.00 | 35,134 |
Sep 10, 2025 | 192.50 | 195.00 | 186.00 | 187.50 | 9,771 |
Sep 9, 2025 | 195.00 | 197.00 | 191.00 | 192.50 | 6,599 |
Sep 8, 2025 | 197.50 | 199.00 | 190.00 | 195.00 | 10,378 |
More Faron Pharmaceuticals Oy Historic Prices >Faron Pharmaceuticals Oy Information
Name | Faron Pharmaceuticals Oy | Index | FTSE AIM 100 |
---|
ISIN | FI4000153309 | Epic | FARN |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 750 | Trading Status | Closed |
---|
Shares in Issue | 111.95 m | Prev Close | 185.00p |
---|
PE Ratio | | Market Cap | £207.12 m |
---|
Div Yield | 0 | Div per Share | €NaN |
---|
EPS | -€0.18 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 1.891529 | Quick Ratio | 1.891529 |
---|
Faron Pharmaceuticals Oy Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
30/06/25 | BUY | Juho Jalkanen | RES | 2,000 @ €2.27 | €4,540.00 |
30/06/25 | BUY | Juho Jalkanen | RES | 22,127 @ €2.26 | €50,007.00 |
05/06/25 | SELL | Markku Jalkanen | CEO | 100,000 @ €3.00 | €300,390.00 |
05/06/25 | TOUT | Markku Jalkanen | CEO | 100,000 @ €0.00 | €0.00 |
05/06/25 | SELL | Markku Jalkanen | CEO | 200,000 @ €3.10 | €619,632.00 |
05/06/25 | TOUT | Markku Jalkanen | CEO | 400,000 @ €0.00 | €0.00 |
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Yrjo Wichmann | RES | 2,333 @ £0.00 | £0.00 |
24/06/24 | TIN | Tuomo Patsi | NED | 6,667 @ £0.00 | £0.00 |
More Faron Pharmaceuticals Oy Director Deals >Faron Pharmaceuticals Oy News